Dosage and Administration

Dosage and Administration

Guidelines and Recommendations

FOR SUBCUTANEOUS USE ONLY¹

• Do not inject intravascularly
• Do not give immune globulin (IG) concurrently with M-M-R^® _II.
• The dose for any age is 0.5 ml administered subcutaneously, preferably into the outer aspect of the upper arm.
• Individuals first vaccinated at 12 months of age or older should be revaccinated at 4-6 years of age or 11-12 years of age. Revaccination is intended to seroconvert those who do not respond to the first dose.

GUIDELINES AND RECOMMENDATIONS

GUIDELINES AND RECOMMENDATIONS

Individuals at 12 months to 12 years of age¹

1^st Dose

12 months of age and above.

2^nd Dose

Recommended at 4-6 years old if 1^st dose is taken at 12 months of age or older.

More about M-M-R^®II

Disease

Measles is an infectious disease that is highly contagious with symptoms of high fever, cough, red eyes, and rashes on the skin.

ONLY M-M-R^® _II Vaccine

The ONLY M-M-R^® _II Vaccine with the original Jeryl Lynn Mumps Strain

References:

1. MMR-II LPC. S-IPC-V205C-I-022020.

PH-MMR-00015 Oct/2024